EUVIMEDEUVIMED entdecken
Open Access

Cryobioprinted human tumor models with shelf-stable programmability

Maria V Monteiro, Carlos Ezio Garciamendez-Mijares, David Sebastián Rendon Ruiz, Mafalda S Borralho, Rui Vitorino, Iola F Duarte, Vítor M Gaspar, Yu Shrike Zhang, João F Mano

Trends in Biotechnology · 2026-02 · 44 (2) · 401-429

DOI: 10.1016/j.tibtech.2025.09.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-02. Verfasst von Maria V Monteiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal. Hauptthemen laut MEDLINE: Cryopreservation, Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, National Research Foundation of Korea, Chan Zuckerberg Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryobioprinting enables simultaneous fabrication and cryopreservation of tissue analogs, surpassing the limitations of print-to-use biofabrication approaches. However, cryopreservation of living constructs remains challenging, requiring optimal cryopreservation conditions tailored to specific cell types and hydrogel bioinks. To address this, we explored the formulation of a decellularized extracellular matrix (dECM)-based hydrogel bioink containing cryoprotective agents (CPAs) to generate shelf-ready tumor-stroma pancreatic cancer models. Combinatorial screening of CPAs led to the discovery of a novel melezitose-glycerol-dECM formulation that exhibited superior cryoprotective properties in both tumor and stroma compartments. Exometabolomics analysis revealed that cryopreserved constructs exhibited similar metabolic activity to nonfrozen counterparts 14 days post thawing. Cryobioprinted tumor-stroma models in dECM-CPA bioinks also exhibited increased cell viability post thawing and suitable features for in vitro drug screening. Thus, our optimized cryoprotective strategy opens new opportunities to potentially explore any type of tissue decellularized bioinks for cryobioprinting off-the-shelf living constructs for widespread drug screening and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryopreservationPancreatic NeoplasmsHumansCryoprotective AgentsExtracellular MatrixHydrogelsCell SurvivalCell Line, TumorTissue Engineering

Stichwörter der Autor:innen

3D in vitro modelsbioinkcryobioprintingcryoprotective agentspancreatic cancer

Substanzen

Cryoprotective AgentsHydrogels

Autor:innen und Institutionen

  • Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal.
  • Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
  • Department of Medical Sciences, Institute of Biomedicine iBiMED, University of Aveiro, 3810-193, Aveiro, Portugal.
  • Department of Chemistry, LAQV-REQUIMTE, University of Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal.
  • Department of Chemistry, CICECO - Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal. Electronic address: vm.gaspar@ua.pt.
  • Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA; Bro…

Förderung

  • NIBIB NIH HHS
  • National Research Foundation of Korea
  • Chan Zuckerberg Initiative
  • Ministério da Educação e Ciência
  • Laboratório Associado para a Química Verde
  • Programa Operacional Temático Factores de Competitividade
  • Ministry of Science and ICT, South Korea
  • Brigham Research Institute

Zitieren

APA

Monteiro, M. V., Garciamendez-Mijares, C. E., Ruiz, D. S. R., Borralho, M. S., Vitorino, R., Duarte, I. F., Gaspar, V. M., Zhang, Y. S., & Mano, J. F. (2026). Cryobioprinted human tumor models with shelf-stable programmability. Trends in Biotechnology, 44(2), 401-429. https://doi.org/10.1016/j.tibtech.2025.09.018

Vancouver

Monteiro MV, Garciamendez-Mijares CE, Ruiz DSR, Borralho MS, Vitorino R, Duarte IF, et al. Cryobioprinted human tumor models with shelf-stable programmability. Trends in Biotechnology. 2026;44(2):401-429. doi:10.1016/j.tibtech.2025.09.018

BibTeX
@article{Monteiro2026,
  author = {Monteiro, Maria V and Garciamendez-Mijares, Carlos Ezio and Ruiz, David Sebastián Rendon and Borralho, Mafalda S and Vitorino, Rui and Duarte, Iola F and Gaspar, Vítor M and Zhang, Yu Shrike and Mano, João F},
  title = {Cryobioprinted human tumor models with shelf-stable programmability},
  journal = {Trends in Biotechnology},
  year = {2026},
  volume = {44},
  number = {2},
  pages = {401--429},
  doi = {10.1016/j.tibtech.2025.09.018}
}
Kostenlos starten →